Published in JAMA on July 10, 1991
Racial differences in incident heart failure among young adults. N Engl J Med (2009) 5.60
The impact of obesity on the left ventricle: the Multi-Ethnic Study of Atherosclerosis (MESA). JACC Cardiovasc Imaging (2010) 2.69
Favorable changes in cardiac geometry and function following gastric bypass surgery: 2-year follow-up in the Utah obesity study. J Am Coll Cardiol (2011) 2.26
Body mass index and vigorous physical activity and the risk of heart failure among men. Circulation (2008) 2.19
Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol (2012) 2.10
Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet (2012) 1.90
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation (2009) 1.75
The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med (2008) 1.73
The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis. PLoS Med (2013) 1.70
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation (2010) 1.62
The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults. Diabetologia (2010) 1.61
Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol (2007) 1.55
Risk factors for heart failure: a population-based case-control study. Am J Med (2009) 1.52
Cardiac remodeling at the population level--risk factors, screening, and outcomes. Nat Rev Cardiol (2011) 1.43
Associations of childhood and adult obesity with left ventricular structure and function. Int J Obes (Lond) (2016) 1.40
Obesity-related cardiovascular risk factors after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention. Eur J Endocrinol (2010) 1.37
Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification. Int J Cardiovasc Imaging (2010) 1.35
The Role of Overweight and Obesity in the Cardiorenal Syndrome. Cardiorenal Med (2011) 1.35
Nebivolol improves diastolic dysfunction and myocardial remodeling through reductions in oxidative stress in the Zucker obese rat. Hypertension (2010) 1.32
Association of multiple anthropometrics of overweight and obesity with incident heart failure: the Atherosclerosis Risk in Communities study. Circ Heart Fail (2009) 1.30
Adaptation and maladaptation of the heart in obesity. Hypertension (2008) 1.29
Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J (2008) 1.24
Effect of moderate diet-induced weight loss and weight regain on cardiovascular structure and function. J Am Coll Cardiol (2009) 1.17
Adipose tissue biology and cardiomyopathy: translational implications. Circ Res (2012) 1.05
Cardiovascular disease among hispanics and non-hispanics in the chronic renal insufficiency cohort (CRIC) study. Clin J Am Soc Nephrol (2011) 1.05
Relation of regional fat distribution to left ventricular structure and function. Circ Cardiovasc Imaging (2013) 1.04
Cathepsin K knockout mitigates high-fat diet-induced cardiac hypertrophy and contractile dysfunction. Diabetes (2012) 1.02
Prevalence of self-reported hypertension and its relation to dietary habits, in adults; a nutrition & health survey in Greece. BMC Public Health (2006) 1.01
The natural history of left ventricular geometry in the community: clinical correlates and prognostic significance of change in LV geometric pattern. JACC Cardiovasc Imaging (2014) 1.01
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community. Am Heart J (2007) 0.99
Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age. Am J Cardiol (2009) 0.99
Obesity and cardiac risk after kidney transplantation: experience at one center and comprehensive literature review. Transplantation (2008) 0.96
Obesity is associated with left atrial enlargement, E/A reversal and left ventricular hypertrophy. Exp Clin Cardiol (2008) 0.95
Obesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunities. Transl Res (2014) 0.94
Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. Heart (1997) 0.90
The association of left ventricular hypertrophy with metabolic syndrome is dependent on body mass index in hypertensive overweight or obese patients. PLoS One (2011) 0.89
Effects of body size and body fatness on left ventricular mass in children and adolescents: Project HeartBeat! Am J Prev Med (2009) 0.88
Patterns of body fat deposition in youth and their relation to left ventricular markers of adverse cardiovascular prognosis. Am J Cardiol (1999) 0.87
Increased incidence of diuretic use in critically ill obese patients. J Crit Care (2015) 0.85
Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish, prospective cohort study. PLoS One (2015) 0.84
Molecular determinants of the cardiometabolic phenotype. Endocr Metab Immune Disord Drug Targets (2010) 0.84
Hypertension and combinations of cardiovascular risk factors. An epidemiologic case-control study in an adult population in Guadeloupe (FWI). Eur J Epidemiol (2001) 0.84
Associations between childhood body size, composition, blood pressure and adult cardiac structure: the Fels Longitudinal Study. PLoS One (2014) 0.84
Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. Am J Cardiol (2013) 0.83
Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study. Obesity (Silver Spring) (2014) 0.83
Body Mass Index or Microalbuminuria, Which One is More Important for the Prediction and Prevention of Diastolic Dysfunction in Non-diabetic Hypertensive Patients? Int J Prev Med (2012) 0.83
Childhood obesity increases left-ventricular mass irrespective of blood pressure status. Pediatr Cardiol (2013) 0.83
Insulin resistance and plasma triglyceride level are differently related to cardiac hypertrophy and arterial stiffening in hypertensive subjects. Vasc Health Risk Manag (2006) 0.82
(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism. Heart Fail Rev (2013) 0.82
Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study. Circ Cardiovasc Genet (2010) 0.82
Association of the degree of adiposity and duration of obesity with measures of cardiac structure and function: the CARDIA study. Obesity (Silver Spring) (2014) 0.82
Incidence, Predictors, and Impact of Postoperative Atrial Fibrillation after Coronary Artery Bypass Grafting in Military Veterans. Tex Heart Inst J (2016) 0.81
Assessment of Myocardial Ischemia in Obese Individuals Undergoing Physical Stress Echocardiography (PSE). Arq Bras Cardiol (2015) 0.80
The pathogenesis of hypertension in obese subjects. Drugs (1993) 0.80
The Role of Obesity in the Development of Left Ventricular Hypertrophy Among Children and Adolescents. Curr Hypertens Rep (2016) 0.79
Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity. J Transl Med (2013) 0.79
Which measures of adiposity predict subsequent left ventricular geometry? Evidence from the Bogalusa Heart Study. Nutr Metab Cardiovasc Dis (2014) 0.76
Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study. Am J Nephrol (2016) 0.75
Prevalence and determinants of left ventricular hypertrophy in hypertensive patients at a primary care clinic. Malays Fam Physician (2012) 0.75
Myofilament function and body mass index. Biomed Rep (2017) 0.75
Left ventricular mass: correlation with fatness, hemodynamics and renal morphology. Pol J Radiol (2014) 0.75
Early detection of regional and global left ventricular myocardial function using strain and strain-rate imaging in patients with metabolic syndrome. Chin Med J (Engl) (2015) 0.75
Higher protein intake increases cardiac function parameters in healthy children: metabolic programming by infant nutrition-secondary analysis from a clinical trial. Pediatr Res (2016) 0.75
Association of body surface area and body composition with heart structural characteristics of female swimmers. Int J Exerc Sci (2010) 0.75
Obesity alters molecular and functional cardiac responses to ischemia/reperfusion and glucagon-like peptide-1 receptor agonism. Basic Res Cardiol (2016) 0.75
Residual urinary output in high body mass index individuals on chronic hemodialysis: A disregarded life vest? World J Nephrol (2014) 0.75
Association of Weight and Body Composition on Cardiac Structure and Function in the ARIC Study (Atherosclerosis Risk in Communities). Circ Heart Fail (2016) 0.75
Review Of Obesity And Atrial Fibrillation: Exploring The Paradox. J Atr Fibrillation (2015) 0.75
Independent associations of glucose status and arterial stiffness with left ventricular diastolic dysfunction: an 8-year follow-up of the Hoorn Study. Diabetes Care (2012) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study. BMC Cardiovasc Disord (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol (2000) 4.48
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
The somatic replication of DNA methylation. Cell (1981) 4.42
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
An improved method for adjusting the QT interval for heart rate (the Framingham Heart Study) Am J Cardiol (1992) 3.66
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86